Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model

The H7N9 influenza virus causes a severe form of disease in humans. Neuraminidase inhibitors, including oral oseltamivir and injectable peramivir, are the first choices of antiviral treatment for such cases; however, the clinical efficacy of these drugs is questionable. Animal experimental models ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Farooqui, Amber, Huang, Linxi, Wu, Suwu, Cai, Yingmu, Su, Min, Lin, Pengzhou, Chen, Weihong, Fang, Xibin, Zhang, Li, Liu, Yisu, Zeng, Tiansheng, Paquette, Stephane G., Khan, Adnan, Kelvin, Alyson A., Kelvin, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2015
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649212/
https://www.ncbi.nlm.nih.gov/pubmed/26369969
http://dx.doi.org/10.1128/AAC.01885-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649212/
https://www.ncbi.nlm.nih.gov/pubmed/26369969
http://dx.doi.org/10.1128/AAC.01885-15

Ejemplares similares